University of North Carolina at Chapel Hill is a clinical research site located in Raleigh, North Carolina, United States 27599.
Crixeo Clinical Trials Trust Score: 94/100 (GOOD). This profile has not yet been claimed by the site owner.
University of North Carolina at Chapel Hill has participated in 4 clinical trials with 2 currently active.
Therapeutic areas: Plasminogen Deficiency, Schizophrenia, First-Episode Psychosis.
Sponsors: Indiana Hemophilia &Thrombosis Center, Inc., Sumitomo Pharma America, Inc., University of Pennsylvania.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in North Carolina · View every site in Raleigh
Trust Score: 94/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
University of North Carolina at Chapel Hill has a Crixeo Trust Score of 94/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
University of North Carolina at Chapel Hill has 4 clinical trials on record, with 2 currently active. Their work covers Plasminogen Deficiency, Schizophrenia, First-Episode Psychosis.
University of North Carolina at Chapel Hill has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.